EMAIL THIS PAGE TO A FRIEND

Scientific reports

Detection of Infertility-related Neutralizing Antibodies with a Cell-free Microfluidic Method.


PMID 26585778

Abstract

The unwanted emergence of neutralizing antibodies (nAbs) against an endogenous or a therapeutic protein can result in deficiency diseases or therapy failure. Here, we developed a cell-free microfluidic method for the sensitive detection and quantification of nAbs in human serum that are associated with infertility. We used cell-derived vesicles containing the luteinizing hormone (LH)/choriogonadotropin receptor (LHHCGR) to detect nAbs against LH. The method exploits the entire cellular signal amplification mechanism, and facilitates the detection of as little as 0.44 nM of LH-nAb (Kd 1.5 nM) in human serum matrix within only 15 minutes. In addition, dose-response curves can be generated in less than 2 hours to evaluate the nAB concentration and dissociation constant. The developed system is devoid of problems associated with cell-based assays and we believe that this simple effect-directed analysis can be used in clinical environments, and is adaptable to other hormones or cytokines and their respective nAbs.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C3355
Coelenterazine hcp, solid
C25H25N3O2
D9766
Dipyridamole, ≥98% (HPLC)
C24H40N8O4
235709
Octamethyltrisiloxane, 98%
C8H24O2Si3
157767
Sulfuryl chloride, 97%
Cl2O2S
278505
Sulfuryl chloride solution, 1.0 M in methylene chloride
Cl2O2S
677469
Titanium(IV) oxide, contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
O2Ti
718467
Titanium(IV) oxide, nanopowder, 21 nm primary particle size (TEM), ≥99.5% trace metals basis
O2Ti
774510
Titanium(IV) oxide, nanowires, diam. × L ~100 nm × 10 μm
O2Ti
774529
Titanium(IV) oxide, nanowires, diam. × L ~10 nm × 10 μm
O2Ti
637254
Titanium(IV) oxide, anatase, nanopowder, <25 nm particle size, 99.7% trace metals basis
O2Ti
232033
Titanium(IV) oxide, anatase, powder, 99.8% trace metals basis
O2Ti
248576
Titanium(IV) oxide, anatase, powder, −325 mesh, ≥99% trace metals basis
O2Ti
634662
Titanium(IV) oxide, mixture of rutile and anatase, nanopowder, <100 nm particle size (BET), 99.5% trace metals basis
O2Ti
700355
Titanium(IV) oxide, mixture of rutile and anatase, nanoparticle, <250 nm particle size (DLS), paste, 53-57 wt. % in diethylene glycol monobutyl ether/ethylene glycol, 99.9% trace metals basis
O2Ti
700347
Titanium(IV) oxide, mixture of rutile and anatase, nanoparticles, <150 nm particle size (volume distribution, DLS), dispersion, 40 wt. % in H2O, 99.5% trace metals basis
O2Ti
700339
Titanium(IV) oxide, mixture of rutile and anatase, nanoparticles, <100 nm particle size, dispersion, 48-52 wt. % in xylene, 99.9% trace metals basis
O2Ti
204730
Titanium(IV) oxide, rutile, 99.995% trace metals basis
O2Ti
204757
Titanium(IV) oxide, rutile, ≥99.98% trace metals basis
O2Ti
635057
Titanium(IV) oxide, rutile, <001>, (single crystal substrate), ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
O2Ti
635049
Titanium(IV) oxide, rutile, <100>, (single crystal substrate), ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
O2Ti
635065
Titanium(IV) oxide, rutile, <110>, single crystal substrate, ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
O2Ti
637262
Titanium(IV) oxide, rutile, nanopowder, <100 nm particle size, 99.5% trace metals basis
O2Ti
224227
Titanium(IV) oxide, rutile, powder, <5 μm, ≥99.9% trace metals basis
O2Ti